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Abstract
Background: In places with poor vital registration, measurement of maternal mortality and
monitoring the impact of interventions on maternal mortality is difficult and seldom undertaken.
Mortality ratios are often estimated and policy decisions made without robust evidence. This paper
presents a prospective key informant system to measure maternal mortality and the initial findings
from the system.
Methods: In a population of 228 186, key informants identified all births and deaths to women of
reproductive age, prospectively, over a period of 110 weeks. After birth verification, interviewers
visited households six to eight weeks after delivery to collect information on the ante-partum,
intra-partum and post-partum periods, as well as birth outcomes. For all deaths to women of
reproductive age they ascertained whether they could be classified as maternal, pregnancy related
or late maternal and if so, verbal autopsies were conducted.
Results: 13 602 births were identified, with a crude birth rate of 28.2 per 1000 population (C.I.
27.7–28.6) and a maternal mortality ratio of 722 per 100 000 live births (C.I. 591–882) recorded.
Maternal deaths comprised 29% of all deaths to women aged 15–49. Approximately a quarter of
maternal deaths occurred ante-partum, a half intra-partum and a quarter post-partum.
Haemorrhage was the commonest cause of all maternal deaths (25%), but causation varied
between the ante-partum, intra-partum and post-partum periods. The cost of operating the
surveillance system was US$386 a month, or US$0.02 per capita per year.
Conclusion: This low cost key informant surveillance system produced high, but plausible birth
and death rates in this remote population in India. This method could be used to monitor trends
in maternal mortality and to test the impact of interventions in large populations with poor vital
registration and thus assist policy makers in making evidence-based decisions.
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Background
Maternal mortality in the developing world remains high,
with little progress towards Millennium Development
Goal (MDG) 5 [1,2]. There remains little evidence of the
impact of interventions on maternal mortality at the pop-
ulation level in poor and remote areas, where ratios are
often highest. The main challenge in effectively monitor-
ing progress and the impact of interventions is the diffi-
culty in measuring maternal mortality.
Maternal death is a relatively rare event, so large sample
sizes are needed to monitor mortality ratios. Conven-
tional surveillance systems are expensive and logistically
challenging and consequently, there have only been three
published trials that have attempted to measure popula-
tion maternal mortality ratio [3-5]. Furthermore, under-
reporting is frequent with most deaths occurring outside
of the health system and in countries without efficient
vital registration systems. Cause of death assignment is
difficult: where death certificates are completed they do
not stipulate pregnancy status [6,7] and maternal deaths
may be intentionally misclassified [8]. Thus there is a
great need for alternative methods for measuring maternal
mortality [9].
India has the largest number of maternal deaths in the
world and accounts for 22% of all maternal deaths [10].
About two thirds of these occur in just nine states, which
include Jharkhand and Orissa [11]. There are an estimated
90 million indigenous people in India, referred to as
"scheduled tribes" or "adivasis". Research has shown that
an indigenous person in India is 1.2 times more likely to
experience excess mortality compared to a non-indige-
nous person with the same standard of living [12].
This paper presents a prospective key informant system of
birth and death identification that is designed to be
cheaper and simpler than conventional surveillance sys-
tems. It aims to: measure crude birth rates and maternal
mortality in a remote, predominantly indigenous popula-
tion in eastern India; identify pregnancy related and late
maternal deaths; ascertain the breakdown of maternal
deaths by cause and determine the timing and place of
death; and report the cost of the system.
Methods
A key informant surveillance system was established in
three contiguous districts in two states in India; West Sing-
hbhum and Saraikela-Kharswan in Jharkhand and Keon-
jhar in Orissa. Within each district, twelve population
clusters were selected; the average population per cluster
is 6338, covering a total population of 228,186. The clus-
ters are largely physically remote from health services and
comprise a high proportion (73%) of indigenous people.
Other inhabitants are largely from the scheduled (3%)
and other backward castes (24%).
The measurement of maternal mortality is just one com-
ponent of a larger key informant surveillance system
designed to identify all births, neonatal and maternal out-
comes for the duration of a randomised controlled trial.
The whole system is described below but this paper will
just present results and costs for the maternal mortality
component. The system comprises two stages; the identifi-
cation stage and the interviewing stage (Figure 1).
The identification stage utilised local key informants toi-
dentify all births and deaths to women of reproductive age
(15–49). Most key informants were traditional birth
attendants (TBAs). One key informant was recruited to
cover a geographic area of approximately 250 households.
They were paid an incentive of 30 rupees ($0.65) for every
accurate birth or death identification. The key informants
met with an interviewer two-three times a month to pass
on the relevant information and the interviewer in turn
visited the relevant households to verify the births and
deaths before paying the identifiers. The key informers
only missed one late maternal death where a woman had
migrated to work at a brick kiln. In this instance the local
auxillary nurse midwife informed the interviewer.
The interviewing stage utilised one full-time salaried inter-
viewer for each cluster. Their role was to verify the infor-
mation provided by key informants; to interview all
mothers six weeks after their delivery to collect detailed
information on the ante-partum, intra-partum, and post-
partum periods, as well as background information; and
to interview family members in the case of a death of a
women of reproductive age to ascertain whether she was
pregnant, or had recently given birth. The interviewer
ascertained whether a death was maternal, late maternal,
pregnancy related or none of these by interviewing rela-
tives of the deceased, without the use of a verbal autopsy
tool. Eighty two per cent of all interviews were conducted
between six to eight weeks after delivery.
One monitoring supervisor per district supervised the sur-
veillance system. In the case of a maternal, pregnancy
related or late maternal death they conducted verbal
autopsies with a close friend or relative of the mother, ide-
ally present at the time of death. 47 verbal autopsies were
with husbands; 55 with other relatives and one with a
friend. 94 of the 103 respondents were present at the time
of death. Supervisors also tried to conduct verbal autop-
sies with formal and informal care providers, present at
the time of death, but these proved more difficult and
only seventeen out of a possible 37 providers were inter-
viewed. 70% of maternal verbal autopsies were conducted
within eight weeks after delivery.
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Verbal autopsies were reviewed independently by two
local obstetricians from the study area. There was agree-
ment on primary causation in all but seven cases. In the
case of disagreement a third doctor was consulted.
Finally, the costs of the surveillance system incurred by
the project were explored. Finanacial data were obtained
from project accounts. Costs were classified in terms of:
identification of births and deaths; eliminating deaths to
women of reproductive age that were not maternal, late
maternal or pregnancy related by interviewers; interviews,
verbal autopsies; and data management (including data-
base design, data entry by data entry clerk and data analy-
sis by a number of project staff, and associated
equipment). The cost of verbal autopsies included the cost
of the supervisor and obstetricians time assigning cause of
death. Although, the obstetricians volunteered their time,
and were not paid by the project, their time was valued
using average salary rates as, in the case of scale-up to a
larger population, an incentive payment may be neces-
sary. Costs are presented as average monthly costs and as
unit costs (e.g. cost per identification). The costs of setting
up the system in terms of staff recruitment and training
were also estimated. Costs are presented in 2006 US dol-
lars ($1= IRS 44.1).
The surveillance system is on-going as it is being used to
monitor the impact of a randomized controlled trial, and
this paper refers to births occurring in the first 110 weeks,
from 21st November 2004 to 31st Dec 2006. Maternal and
pregnancy related deaths may occur up to 42 days after the
birth and are therefore included up until 11th February.
Late maternal deaths may occur up to one year after the
birth and have been followed up until 31st December
2007.
Results
Birth rates and maternal outcomes
In a population of 228 186, over a 110 week period, 13
602 births were identified, of which 13 160 were live
births (Table 1). The crude birth rate is 28 per 1000 pop-
ulation. 323 deaths to women of reproductive age were
identified, of these 29% (95) were classified as maternal
deaths, giving a maternal mortality ratio (MMR) of 722
per 100 000 live births (CI 591–882). Four additional
pregnancy related and four late maternal deaths were
identified.
Cause and timing of maternal deaths
A quarter of all maternal deaths (24%) occurred during
the ante-partum period, half during the intra-partum
Maternal Mortality Key Informant Surveillance SystemFigu e 1
Maternal Mortality Key Informant Surveillance System.
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period and up to 48 hours afterwards (48%) and just over
a quarter up to 42 days post-partum (27%) (Table 2).
Haemorrhage was the primary cause of death for a quarter
of maternal deaths (25%); closely followed by malaria
(23%); and sepsis (17%). Malaria was the most common
cause of death during the ante-partum period (48%);
haemorrhage during the intra-partum period (39%); and
sepsis during the post-partum period (35%). Secondary
causes were also identified from the verbal autopsies.
Anaemia was a key underlying factor in 35% of deaths.
Malaria (22) and Sepsis (20) were also highlighted as key
underlying causes.
The additional pregnancy related deaths were due to sui-
cide, homicide, thyroid cancer and lightening and the late
maternal deaths were due to malaria, sepsis, embolism,
and tuberculosis.
220 additional deaths to women of reproductive age were
identified. The most common causes of death were
malaria (46), tuberculosis (28), accidental causes (29),
anaemia (22), gastro-intestinal conditions (20) and sui-
cide (15).
Place of delivery and death
85% of all of the deliveries took place at home, 15% took
place in a facility and 0.1% in transit. For those who died
the percentages were very similar with 87% of the deliver-
ies occurring at home and 13% in a facility.
60% of deaths occurred at home, 28% in a facility, 6% in
transit to a facility and 5% in transit from a facility (Table
3). There was very little variation in the place of death,
when broken down by timing with a similar pattern seen
during the ante-partum, intra-partum, and post-partum
periods.
Table 1: Birth rates and maternal outcomes
95% Confidence Interval
Total Population 228,186
Number of births 13602
Crude birth rate per 1000 population 28.2 (27.7–28.6)
Number of live births 13160
Number of deaths to women of reproductive age (15–49) 323
Number of maternal deaths 95
Number of pregnancy related deaths 99
Number of late maternal deaths* 4
Maternal mortality ratio per 100 000 live births (n) 722 (591–882)
Table 2: Primary causes of maternal deaths by time of death
Primary cause of death Ante-partum Intra-partum (< 48 hours) Post-partum (< 42 days) Total
% (n) % (n) % (n) % (n)
All Deaths 24.2 (23) 48.4 (46) 27.4 (26)
Haemorrhage 8.7 (2) 39.1 (18) 15.4 (4) 25.3 (24)
Malaria 47.8 (11) 10.9 (5) 23.1 (6) 23.2 (22)
Sepsis 4.3 (1) 13.0 (6) 34.6 (9) 16.8 (16)
Hypertensive disorder 21.7 (5) 10.9 (5) 11.5 (3) 13.7 (13)
Obstructed Labour 17.4 (8) 8.4 (8)
Anaemia 3.8 (1) 1.1 (1)
Embolism 7.7 (2) 2.1 (2)
Abortion 8.7 (2) 2.1 (2)
Other direct* 6.5 (3) 3.8 (1) 4.2 (4)
Other indirect** 8.7 (2) 2.2 (1) 3.2 (3)
n = 95
* Retained placenta and obstetric shock
** Tuberculosis and heart disease
BMC Pregnancy and Childbirth 2008, 8:6 http://www.biomedcentral.com/1471-2393/8/6
Page 5 of 8
(page number not for citation purposes)
For those who delivered at home and died, 68% died at
home and 23% made it to a facility, while 3% died in tran-
sit to a facility and 3% in transit from a facility. For those
who delivered in a facility and died, most died in a facility
(89%) while 11% died in transit from the facility. For
those who died during pregnancy 62% died at home, 21%
at a facility, 12% in transit to a facility.
Cost of surveillance system
The average monthly cost of identification was US$ 386
(US$ 0.70 per identification) (Table 4). The average
monthly cost of the monitors eliminating deaths to
women of reproductive age that were not maternal, late
maternal or pregnancy related deaths was US$ 9 (US$ 1
per recording). The average monthly cost of interviews
was US$ 2,311 (US$ 0.17 per interview) and the average
cost of verbal autopsies was US$ 54 (US$ 0.44 per VA).
The average monthly cost of data management and anal-
ysis was US$ 343. The average monthly cost overall was
US$ 2,759 (US$ 0.20 per birth interviewed), or US$ 3,103
inclusive of data management (US$ 0.23 per birth inter-
viewed). Staff represented 84% of the cost; transport 9%
and supplies 5%. The one-off cost of recruiting and train-
ing all staff was US$ 7,355.
Discussion
This study has shown that even in remote, deprived pop-
ulations a key informant system can produce reliable and
plausible maternal mortality ratios at low cost. The key
informant method has several important advantages. The
system is designed to prospectively measure, rather than
estimate, levels of maternal mortality in a given popula-
tion. Most maternal mortality data for developing coun-
tries are estimates, derived retrospectively, from censuses,
facility records and indirect methods such as adding ques-
tions to household or Demographic and Health Surveys
Table 3: Place of death by time of death and place of delivery
Place of death
Home Facility Transit to facility Transit from facility Field
% (n) % (n) % (n) % (n) % (n)
All Deaths 60.2 62 28.2 29 5.8 6 4.9 5 1 1
Time of Death
Ante-partum 60.0 15 32.0 8 8.0 2
Intra-partum (< 48 hours) 58.7 27 21.7 10 8.7 4 10.9 5
Postpartum (< 42 days) 62.5 15 37.5 9
Late maternal deaths (42 days – 1 year) 50.0 2 50.0 2
Pregnancy related 75.0 3 0 25.0 1
Place of delivery
Home 68.3 41 23.3 14 3.3 2 3.3 2 1.7 1
Facility 88.9 8 11.1 1
Died during pregnancy 61.8 21 20.6 7 11.8 4 5.9 2
n = 103
Table 4: Breakdown of the costs of the surveillance system by activity and resource
Cost component Identification Eliminating non-maternal deaths Interviews Verbal Autopsies Total
Key informants 375 - - - 375
Interviewers - 6.83 1 690 - 1 697
Supervisers - 0.88 219 25 245
Obstertician - - - 11 11
Supplies (Printing, stationary) - 0.55 135 - 136
Supplies (Hats, badges, bags) 11 - - - 11
Communication - 0.09 23 1 24
Refreshments - 0.03 7 0 7
Transport - 0.96 238 16 255
Total 386 9.34 2 311 54 2 759
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(DHS). The 'sisterhood method' generates retrospective
data and attempts to overcome sample size problems by
asking all adult women in a household questions about
the survival of their sisters, but often excludes information
on the cause or circumstances surrounding the death [13]
'Networking' tries to further address sample size problems
by asking women if they are aware of any women who
died from maternal causes in the preceding year [14]. To
avoid missing maternal deaths the key informant system
identifies all deaths to women of reproductive age and
subsequently exposes maternal deaths through a process
of elimination. In this respect this system could be consid-
ered to be a prospective variant of 'Reproductive Age Mor-
tality Surveys'. This has the further benefit that it can also
provide useful information about non-maternal deaths to
women of reproductive age if desired. Furthermore, since
the key identifiers identify all births and neonatal out-
comes this process also provides an accurate denomina-
tor.
Few Safer Motherhood programmes or research trials
attempt to measure maternal mortality directly due to the
large sample size required and the perceived high cost
involved. The key informant system is acceptable, feasible
and affordable for epidemiological surveillance of
research or development projects. Mothers were only vis-
ited once, six to eight weeks after delivery. Compared with
methods requiring frequent visits [4], which could poten-
tially result in higher refusal rates, our system reduces
costs and is less intrusive to families. The system may be
seen as similar to conventional demographic surveillance
systems, but differences include the use of incentivised
key informants (who are not health workers and do not
routinely visit every household in a defined area); the
application across a large number of dispersed clusters;
and the relatively low cost. The use of an incentive driven
system avoids ethical dilemmas associated with the use of
unpaid volunteers, while remaining low cost. The essen-
tial cost, in terms of deriving an estimate of the maternal
mortality ratio is simply the cost of identification of
deaths and verification, a monthly cost of US$386 in our
area, or US $0.02 per capita per year.
Concerns that key informers may over report births or
deaths to earn more money are invalid, as payment is only
made once an identification has been verified by inter-
viewers. In regards to missing births or deaths, the inform-
ants were allocated manageable geographical areas, based
on whole hamlets or distinct parts of a village, which are
familiar and accessible, minimising the risk of any births
or deaths being missed. The death of any woman of repro-
ductive age is a significant event that an informant living
in the community would naturally be aware of, enabling
deaths during pregnancy and late maternal deaths to be
captured. However, migration does pose a problem.
The results presented in this paper are for women of the
standard reproductive age group 15–49 years. In the study
all deaths to women aged 10–50 are recorded to ensure
there is no under-reporting of maternal deaths due to age
restrictions, as early marriage is common in this setting
and many people do not know their exact age. However,
during the 110 week study period no maternal deaths
have been found for this age-group and hence results pre-
sented in this paper are just for those aged 15–49.
This method for measuring maternal mortality appears to
be robust, but as with all methods for measuring maternal
mortality in the community there are clearly some limita-
tions. Maternal deaths could be intentionally misclassi-
fied, especially with regards to unsafe abortion. There are
a lot of suicides reported in this population, and the rela-
tives of two women who died due to menstrual problems
refused to give a detailed interview. It is possible that
some of these women may have been pregnant or had
unsafe abortions. Furthermore, using verbal autopsies to
assign the primary cause of death is difficult when no for-
mal provider is present. There was some uncertainty over
assigning malaria, sepsis or anaemia as a cause of death
without the availability of test results. Delays in collecting
data could also lead to recall problems. The sample size of
13660 births, though large, may not be considered
enough for precise maternal mortality measurement.
However, an analysis of the MMR at 60 weeks from 7500
births produced a very similar MMR. Over time, or with a
larger population, the increase in sample size would add
to the robustness of the mortality measurements.
The findings from this surveillance system raise important
issues for policymakers and health professionals. The sys-
tem has produced high, but plausible birth and death
rates in this rural, predominantly indigenous, population
in India. Our observed crude birth rate of 28 births per
1000 population are consistent with state level reports of
29 in Jharkhand and 24 in Orissa [15]. The MMR of 722
per 100 000 live births was alarmingly high for a popula-
tion unaffected by HIV. The most recent estimate of the
MMR for India is 450 per 100 000 live births [10]. The
MMR for Orissa has been reported as 367 per 100,000 live
births [16]. No official figures are currently available for
MMR for Jharkhand (independent of Bihar), but the state
government has indicated that its goal for the MMR for
2006–07 was 407 per 100,000 live births and 325 for
2009–10 [17]. The high levels of mortality in our study
area probably relate to socioeconomic deprivation in
indigenous populations in remote areas in India and
highlight a pressing need for interventions targeted at
improving maternal and newborn care in these vulnerable
populations.
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The tenth version of the International Classification of
Disease recommended two new additions with regard to
measuring maternal mortality; pregnancy related deaths
and late maternal deaths [18]. It is debatable whether the
suicide and homicide deaths should be included as mater-
nal deaths. There is mounting evidence that being preg-
nant may place women at greater risk of dying from
suicide and homicide, and that unwanted pregnancies
might be an important factor for the increased risk [19].
The inclusion of these two deaths from homicide and sui-
cide would raise the MMR from 722 to 737 and including
all pregnancy related deaths would raise it to 752 (i.e.
remaining within the current confidence interval). This
small difference suggests that pregnancy related deaths
could be a useful proxy indicator for maternal deaths in
similar contexts where cause of death data is unavailable.
This supports the argument that it would be worthwhile
including information on death certificates stipulating
pregnancy status [20] to help measure maternal mortality.
This system also enables the identification of late mater-
nal deaths. One justification for this category is that mod-
ern life-sustaining procedures can prolong dying and
delay death. This data show that although late maternal
deaths even occur in a context with very limited access to
quality health care, most maternal deaths did take place
within the time boundaries of the current definition.
It has been estimated that two-thirds of maternal deaths
occur in late pregnancy through to 48 hours after delivery
[6]. This data showed a higher proportion (52%) of
deaths occurring outside the intra-partum period, suggest-
ing that there may be considerable variability in the con-
tribution of the intra-partum period to maternal mortality
in different contexts. Therefore policies solely focusing on
interventions targeting this period may be less appropriate
for vulnerable and excluded populations. Admittedly,
some of those problems occurring in the postpartum
period may be prevented by interventions in the intra-par-
tum period, especially sepsis, and the higher proportion
of deaths occurring outside the intra-partum period may
be partly attributable to the high prevalence of malaria
within this context.
The data show that in this remote rural population, most
maternal deaths took place at home (60%) rather than in
a facility (28%). Other studies suggest that most maternal
deaths occur in facilities, but this evidence relies heavily
on facility records or studies from countries with a higher
proportion of facility deliveries rather than population
data from poor rural communities [20]. It is also feasible
that deaths at home in similar contexts are more likely to
be missed by conventional methods for monitoring
maternal mortality.
Conclusion
The difficulties in measuring maternal mortality are a fre-
quent constraint to having accurate measurements and
monitoring the impact of interventions. Hence there is a
need for alternative approaches and this paper proposes a
key informant surveillance system. The system has pro-
vided valuable and reliable prospective data on maternal
mortality in a remote indigenous population in India.
This approach to measuring maternal mortality should
allow governments and researchers to take an evidence-
based approach to evaluate programmes and strategies for
maternal mortality reduction in even the most vulnerable
and remote communities in the developing world. Similar
sentinel sites in developing countries could produce relia-
ble MMRs and monitor the impact of large scale interven-
tions. If the method works well in this poor, remote
indigenous area with very limited infrastructure and low
levels of education, then it could be replicated almost any-
where.
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